Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

Medulloblastoma: Molecular Classification-Based Personal Therapeutics.

Archer TC, Mahoney EL, Pomeroy SL.

Neurotherapeutics. 2017 Apr;14(2):265-273. doi: 10.1007/s13311-017-0526-y. Review.

PMID:
28386677
2.

Homozygous germ-line mutation of the PMS2 mismatch repair gene: a unique case report of constitutional mismatch repair deficiency (CMMRD).

Ramchander NC, Ryan NA, Crosbie EJ, Evans DG.

BMC Med Genet. 2017 Apr 5;18(1):40. doi: 10.1186/s12881-017-0391-x.

3.

Polymorphisms of insulin receptor substrate 2 are putative biomarkers for pediatric medulloblastoma: considering the genetic susceptibility and pathological diagnoses.

Baocheng W, Zhao Y, Meng W, Han Y, Wang J, Liu F, Qin S, Ma J.

Nagoya J Med Sci. 2017 Feb;79(1):47-54. doi: 10.18999/nagjms.79.1.47.

4.

Modern management of medulloblastoma: Molecular classification, outcomes, and the role of surgery.

Srinivasan VM, Ghali MG, North RY, Boghani Z, Hansen D, Lam S.

Surg Neurol Int. 2016 Dec 28;7(Suppl 44):S1135-S1141. doi: 10.4103/2152-7806.196922. eCollection 2016. Review. No abstract available.

5.

Regulatory single nucleotide polymorphisms (rSNPs) at the promoters 1A and 1B of the human APC gene.

Matveeva MY, Kashina EV, Reshetnikov VV, Bryzgalov LO, Antontseva EV, Bondar NP, Merkulova TI.

BMC Genet. 2016 Dec 22;17(Suppl 3):154. doi: 10.1186/s12863-016-0460-8.

6.

Genome-wide quantification of rare somatic mutations in normal human tissues using massively parallel sequencing.

Hoang ML, Kinde I, Tomasetti C, McMahon KW, Rosenquist TA, Grollman AP, Kinzler KW, Vogelstein B, Papadopoulos N.

Proc Natl Acad Sci U S A. 2016 Aug 30;113(35):9846-51. doi: 10.1073/pnas.1607794113. Epub 2016 Aug 15.

7.

Thyroid, Renal, and Breast Carcinomas, Chondrosarcoma, Colon Adenomas, and Ganglioneuroma: A New Cancer Syndrome, FAP, or Just Coincidence.

Atta IS, AlQahtani FN.

Case Rep Med. 2016;2016:2928084. doi: 10.1155/2016/2928084. Epub 2016 Mar 20.

8.

Microtubule plus-end tracking proteins in neuronal development.

van de Willige D, Hoogenraad CC, Akhmanova A.

Cell Mol Life Sci. 2016 May;73(10):2053-77. doi: 10.1007/s00018-016-2168-3. Epub 2016 Mar 11. Review.

9.

Inactivating MUTYH germline mutations in pediatric patients with high-grade midline gliomas.

Kline CN, Joseph NM, Grenert JP, van Ziffle J, Yeh I, Bastian BC, Mueller S, Solomon DA.

Neuro Oncol. 2016 May;18(5):752-3. doi: 10.1093/neuonc/now013. Epub 2016 Feb 21. No abstract available.

10.

Molecular approach to genetic and epigenetic pathogenesis of early-onset colorectal cancer.

Tezcan G, Tunca B, Ak S, Cecener G, Egeli U.

World J Gastrointest Oncol. 2016 Jan 15;8(1):83-98. doi: 10.4251/wjgo.v8.i1.83. Review.

11.

Genetic and molecular alterations across medulloblastoma subgroups.

Skowron P, Ramaswamy V, Taylor MD.

J Mol Med (Berl). 2015 Oct;93(10):1075-84. doi: 10.1007/s00109-015-1333-8. Epub 2015 Sep 9. Review.

12.

Medulloblastoma.

Millard NE, De Braganca KC.

J Child Neurol. 2016 Oct;31(12):1341-53. doi: 10.1177/0883073815600866. Epub 2015 Sep 2. Erratum in: J Child Neurol. 2016 Sep 15;:.

PMID:
26336203
13.

Biology of colorectal cancer.

Arvelo F, Sojo F, Cotte C.

Ecancermedicalscience. 2015 Apr 9;9:520. doi: 10.3332/ecancer.2015.520. eCollection 2015. Review.

14.

Analysis of chromosome 17 miRNAs and their importance in medulloblastomas.

López-Ochoa S, Ramírez-García M, Castro-Sierra E, Arenas-Huertero F.

Biomed Res Int. 2015;2015:717509. doi: 10.1155/2015/717509. Epub 2015 Mar 19. Review.

15.

PMS2 monoallelic mutation carriers: the known unknown.

Goodenberger ML, Thomas BC, Riegert-Johnson D, Boland CR, Plon SE, Clendenning M, Win AK, Senter L, Lipkin SM, Stadler ZK, Macrae FA, Lynch HT, Weitzel JN, de la Chapelle A, Syngal S, Lynch P, Parry S, Jenkins MA, Gallinger S, Holter S, Aronson M, Newcomb PA, Burnett T, Le Marchand L, Pichurin P, Hampel H, Terdiman JP, Lu KH, Thibodeau S, Lindor NM.

Genet Med. 2016 Jan;18(1):13-9. doi: 10.1038/gim.2015.27. Epub 2015 Apr 9. Review.

16.

Biflavone Ginkgetin, a Novel Wnt Inhibitor, Suppresses the Growth of Medulloblastoma.

Ye ZN, Yu MY, Kong LM, Wang WH, Yang YF, Liu JQ, Qiu MH, Li Y.

Nat Prod Bioprospect. 2015 Mar 29. [Epub ahead of print]

17.

ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes.

Syngal S, Brand RE, Church JM, Giardiello FM, Hampel HL, Burt RW; American College of Gastroenterology.

Am J Gastroenterol. 2015 Feb;110(2):223-62; quiz 263. doi: 10.1038/ajg.2014.435. Epub 2015 Feb 3. Review.

18.

The mutational spectrum of Lynch syndrome in cyprus.

Loizidou MA, Neophytou I, Papamichael D, Kountourakis P, Vassiliou V, Marcou Y, Kakouri E, Ioannidis G, Philippou C, Spanou E, Tanteles GA, Anastasiadou V, Hadjisavvas A, Kyriacou K.

PLoS One. 2014 Aug 18;9(8):e105501. doi: 10.1371/journal.pone.0105501. eCollection 2014.

19.

Diagnostic application of high resolution single nucleotide polymorphism array analysis for children with brain tumors.

Roth JJ, Santi M, Rorke-Adams LB, Harding BN, Busse TM, Tooke LS, Biegel JA.

Cancer Genet. 2014 Apr;207(4):111-23. doi: 10.1016/j.cancergen.2014.03.002. Epub 2014 Mar 15.

20.

Targeted deletion of the C-terminus of the mouse adenomatous polyposis coli tumor suppressor results in neurologic phenotypes related to schizophrenia.

Onouchi T, Kobayashi K, Sakai K, Shimomura A, Smits R, Sumi-Ichinose C, Kurosumi M, Takao K, Nomura R, Iizuka-Kogo A, Suzuki H, Kondo K, Akiyama T, Miyakawa T, Fodde R, Senda T.

Mol Brain. 2014 Mar 29;7:21. doi: 10.1186/1756-6606-7-21.

Supplemental Content

Support Center